This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Academic Medical Centers  • Conflict of Interest  • Medical Education  • Medical Ethics  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

David J. Rothman, PhD; Susan Chimonas, PhD

JAMA. 2008;300(9):1067-1069.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Over the past 2 years, policies governing the relationship between physicians and pharmaceutical and device companies have undergone remarkable changes. A 2004 task force appointed by the American Board of Internal Medicine Foundation (ABIM) and the Institute on Medicine as a Profession (IMAP) found existing guidelines to be lax.¹ At that time, the industry's Pharmaceutical Research and Manufacturers of America (PhRMA) Code ignored many salient issues, such as disclosure, speaker's bureaus, and ghostwriting and set only modest boundaries around dispensing food, gifts, and travel reimbursements.² The American Medical Association's ethical guidelines largely duplicated PhRMA’s; however, on such practices as gift taking, it was even more permissive.³ The American College of Physicians acknowledged the influence of gifts on physician practices but did not prohibit them.⁴ Government bodies, including the Office of the Inspector General of Health and Human Services, essentially endorsed the PhRMA Code.⁵ . . . [Full Text of this Article]

Author Affiliations: Center on Medicine as a Profession (Drs Rothman and Chimonas), Columbia College of Physicians and Surgeons, and Institute on Medicine as a Profession (Dr Rothman), New York, New York; and Prescription Project (Drs Rothman and Chimonas), Boston, Massachusetts.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer?
Hietanen
Ann Oncol 2009;20:1749-1751.
FULL TEXT  

An Official American Thoracic Society Policy Statement: Managing Conflict of Interest in Professional Societies
Schunemann et al.
Am. J. Respir. Crit. Care Med. 2009;180:564-580.
ABSTRACT | FULL TEXT